Government Briefs

Did Someone Say Profit? The debate over potential conflicts of interest in science may be a hot topic among life scientists (The Scientist, Oct. 16, 1989, page 1). But judging from the comments of two Washington policymakers, the debate hasn’t filtered down to all segments of the scientific community. Sen. Pete Domenici (R-N.M.) recently gave a speech marking a new report from the National Academy of Sciences on opportunities in materials science that emphasizes how industry, academia, a

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The debate over potential conflicts of interest in science may be a hot topic among life scientists (The Scientist, Oct. 16, 1989, page 1). But judging from the comments of two Washington policymakers, the debate hasn’t filtered down to all segments of the scientific community. Sen. Pete Domenici (R-N.M.) recently gave a speech marking a new report from the National Academy of Sciences on opportunities in materials science that emphasizes how industry, academia, and government must work together to maintain U.S. leadership in the field. Following the speech, Domenici was asked how the government would make sure that individuals did not profit from work donewith public funding. “I don’t see the problem,” Domenici said. “We’ll never make any progress in our economy unless someone can profit from a discovery. If I had to choose between holding back development, and letting an individual profit from publicly supported research, I’d opt for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery